1 report

THE DRUG IS INDICATED FOR THE MAINTENANCE OF ASTHMA IN PATIENTS ONE YEAR OF AGE AND OLDER.

  • Asthma
  • Australia
  • United States
  • Demand
  • Sunovion Pharmaceuticals Inc.